Search Results

You are looking at 91 - 100 of 912 items for :

  • "community" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

Hamdy A. Azim, Abdul-Rahman Jazieh, and Mohammad Jahanzeb

approximately 15% of all cancer patients worldwide. Although this example shows its far-reaching benefit, it also shows that there is plenty of room for expanding its application. A real need exists within the oncology community to have a reliable evidence

Full access

Jagar Jasem, Christine M. Fisher, Arya Amini, Elena Shagisultanova, Rachel Rabinovitch, Virginia F. Borges, Anthony Elias, and Peter Kabos

classified into categories of 18 to 25 and 26 to 30. Cancer centers were divided according to the NCI classification into (1) community centers that treat 100 to 500 newly diagnosed cancer cases annually, (2) comprehensive community centers that treat ≥500

Full access

Sharyn F. Worrall, Andrea J. Dwyer, Reese M. Garcia, Keavy E. McAbee, and Anjelica Q. Davis

, these unmet needs must be identified and prioritized within the CRC population. Although efforts to improve the patient and survivor experience have gained momentum over the past decade, it is essential to ensure that the CRC community has their needs

Full access

Richard Li, Wei-Hsien Hou, Joseph Chao, Yanghee Woo, Scott Glaser, Arya Amini, Rebecca A. Nelson, and Yi-Jen Chen

(OR, 1.68; 95% CI, 1.43–1.99; P <.001), Charlson-Deyo comorbidity score ≥2 (OR, 1.46; 95% CI, 1.18–1.81; P <.001), treatment at community facility rather than academic (OR, 1.27; 95% CI, 1.07–1.51; P =.006), and T2 disease compared with the

Full access

Matthew P. Banegas, Linda C. Harlan, Bhupinder Mann, and K. Robin Yabroff

RCC in community practice were examined, focusing on systemic therapy. Patients and Methods Data Source and Study Sample NCI Patterns of Care Data: The NCI SEER program collects information on all cancer diagnoses in defined geographic

Full access

Anusha Ponduri, David Z. Liao, Nicolas F. Schlecht, Gregory Rosenblatt, Michael B. Prystowsky, Rafi Kabarriti, Madhur Garg, Thomas J. Ow, Bradley A. Schiff, Richard V. Smith, and Vikas Mehta

. Methods We identified 184 cases of primary adult HNSCC treated at an urban, community-based academic health center between March 1, 2005, and March 8, 2017. The study protocol was approved by the Institutional Review Board (IRB 2018-9739). Patients with

Full access

Judy Perotti, Elda Railey, Mary Lou Smith, and Cheya Pope

Full access

Rodger J. Winn

Full access

Peter R. Carroll and Andrew J. Vickers

Few clinical issues have polarized the oncology community as much as screening for prostate cancer, with advocates of prostate-specific antigen (PSA) testing vocal on one side and skeptics just as vocal on the other. At the NCCN 19th Annual Conference, Dr. Peter R. Carroll and Dr. Andrew J. Vickers tackled the controversy surrounding early detection of prostate cancer, focusing attention on the randomized trial results at the heart of the matter; over-detection (the Achilles’ heel of screening); and the rationale behind the new, streamlined 2014 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection, which emphasize selective early detection and treatment and are tightly aligned with the NCCN Guidelines for Prostate Cancer.